Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 4576

  • Unknown sort schema '{last_sort_schema}' ignored
  • The following term was not found in PubMed: WC%5BAuthor%5D.

Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes.

Tan RH, Kril JJ, Yang Y, Tom N, Hodges JR, Villemagne VL, Rowe CC, Leyton CE, Kwok JBJ, Ittner LM, Halliday GM.

Alzheimers Dement (Amst). 2017 May 29;9:10-20. doi: 10.1016/j.dadm.2017.05.005. eCollection 2017.


A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.

Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS.

Alzheimers Dement (Amst). 2017 May 30;8:147-155. doi: 10.1016/j.dadm.2017.05.003. eCollection 2017.


Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.

van Wijk N, Slot RER, Duits FH, Strik M, Biesheuvel E, Sijben JWC, Blankenstein MA, Bierau J, van der Flier WM, Scheltens P, Teunissen CE.

Alzheimers Dement (Amst). 2017 May 16;8:139-146. doi: 10.1016/j.dadm.2017.04.005. eCollection 2017.


Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease.

Zufferey V, Donati A, Popp J, Meuli R, Rossier J, Frackowiak R, Draganski B, von Gunten A, Kherif F.

Alzheimers Dement (Amst). 2017 May 31;7:107-114. doi: 10.1016/j.dadm.2017.05.002. eCollection 2017.


Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin.

Carro E, Bartolomé F, Bermejo-Pareja F, Villarejo-Galende A, Molina JA, Ortiz P, Calero M, Rabano A, Cantero JL, Orive G.

Alzheimers Dement (Amst). 2017 May 26;8:131-138. doi: 10.1016/j.dadm.2017.04.002. eCollection 2017.


Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample.

Jung Y, Boot BP, Mielke MM, Ferman TJ, Geda YE, McDade E, Christianson TJH, Knopman DS, St Louis EK, Silber MH, Petersen RC, Boeve BF.

Alzheimers Dement (Amst). 2017 May 30;8:127-130. doi: 10.1016/j.dadm.2017.05.004. eCollection 2017.


Dissociation of Down syndrome and Alzheimer's disease effects with imaging.

Matthews DC, Lukic AS, Andrews RD, Marendic B, Brewer J, Rissman RA, Mosconi L, Strother SC, Wernick MN, Mobley WC, Ness S, Schmidt ME, Rafii MS.

Alzheimers Dement (N Y). 2016 Jun;2(2):69-81. doi: 10.1016/j.trci.2016.02.004.


Multifactorial Analysis of a Biomarker Pool for Alzheimer Disease Risk in a North Indian Population.

Talwar P, Grover S, Sinha J, Chandna P, Agarwal R, Kushwaha S, Kukreti R.

Dement Geriatr Cogn Disord. 2017 Jun 21;44(1-2):25-34. doi: 10.1159/000477206. [Epub ahead of print]


Post-traumatic stress disorder and risk of dementia among members of a health care delivery system.

Flatt JD, Gilsanz P, Quesenberry CP Jr, Albers KB, Whitmer RA.

Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30221-2. doi: 10.1016/j.jalz.2017.04.014. [Epub ahead of print]


Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.

Drachman DA, Smith TW, Alkamachi B, Kane K.

Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30219-4. doi: 10.1016/j.jalz.2017.05.003. [Epub ahead of print]


Practical risk score for 5-, 10-, and 20-year prediction of dementia in elderly persons: Framingham Heart Study.

Li J, Ogrodnik M, Devine S, Auerbach S, Wolf PA, Au R.

Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30220-0. doi: 10.1016/j.jalz.2017.04.013. [Epub ahead of print]


Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression.

Wattmo C, Wallin ÅK.

Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):172-187. doi: 10.1159/000455943. eCollection 2017 Jan-Apr.


Multi-Infarct Dementia: A Historical Perspective.

McKay E, Counts SE.

Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):160-171. doi: 10.1159/000470836. eCollection 2017 Jan-Apr. Review.


Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia.

Corso G, Cristofano A, Sapere N, la Marca G, Angiolillo A, Vitale M, Fratangelo R, Lombardi T, Porcile C, Intrieri M, Di Costanzo A.

Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):143-159. doi: 10.1159/000466688. eCollection 2017 Jan-Apr.


Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study.

Pakdaman H, Amini Harandi A, Abbasi M, Delavar Kasmaei H, Ashrafi F, Gharagozli K, Assarzadegan F, Behnam B, Arabahmadi M.

Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):136-142. doi: 10.1159/000458521. eCollection 2017 Jan-Apr.


Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia.

van den Berg E, Jiskoot LC, Grosveld MJH, van Swieten JC, Papma JM.

Dement Geriatr Cogn Disord. 2017 Jun 17;44(1-2):35-44. doi: 10.1159/000477538. [Epub ahead of print]


Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline.

Yu L, Lutz MW, Farfel JM, Wilson RS, Burns DK, Saunders AM, De Jager PL, Barnes LL, Schneider JA, Bennett DA.

Alzheimers Dement. 2017 Jun 15. pii: S1552-5260(17)30217-0. doi: 10.1016/j.jalz.2017.05.002. [Epub ahead of print]


Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities Study.

Bancks MP, Alonso A, Gottesman RF, Mosley TH, Selvin E, Pankow JS.

Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30196-6. doi: 10.1016/j.jalz.2017.04.006. [Epub ahead of print]


Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.

Crane PK, Trittschuh E, Mukherjee S, Saykin AJ, Sanders RE, Larson EB, McCurry SM, McCormick W, Bowen JD, Grabowski T, Moore M, Bauman J, Gross AL, Keene CD, Bird TE, Gibbons LE, Mez J; Executive Prominent Alzheimer's Disease: Genetics and Risk Factors (EPAD:GRF) Investigators.

Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30216-9. doi: 10.1016/j.jalz.2017.04.011. [Epub ahead of print]


Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.

Persson K, Barca ML, Eldholm RS, Cavallin L, Šaltytė Benth J, Selbæk G, Brækhus A, Saltvedt I, Engedal K.

Dement Geriatr Cogn Disord. 2017 Jun 15;44(1-2):12-24. doi: 10.1159/000477342. [Epub ahead of print]


Supplemental Content

Loading ...
Support Center